https://pubmed.ncbi.nlm.nih.gov/31514337/
Here, we discovered TGFBI as a new urinary biomarker for muscle invasive and high-grade urothelial carcinoma (UC). After biomarker identification using...
tgfbiproteinincreasedurinepatients
https://www.pharmaceutical-technology.com/data-insights/df-6002-dragonfly-therapeutics-transitional-cell-carcinoma-urothelial-cell-carcinoma-likelihood-of-approval/
DF-6002 is under clinical development by Dragonfly Therapeutics and currently in Phase II for Transitional Cell Carcinoma (Urothelial Cell Carcinoma).
transitional cell carcinomadfdragonflytherapeuticsurothelial
https://pubmed.ncbi.nlm.nih.gov/30881713/
Anti-PD-L1 (programmed cell death-ligand 1) agents, such as atezolizumab, have been approved for the treatment of different advanced cancers. However, no study...
safeadministrationantipdatezolizumab
https://clarivate.com/life-sciences-healthcare/report/concon0011-2026-biopharma-bladder-cancer-and-upper-tract-urothelial-carcinoma-geographic-focus-china-bladder-cancer-and/
Bladder cancer is the eighth most diagnosed kind of cancer in China. The bladder cancer therapy market will experience rapid growth over the forecast period,...
bladder cancerupper tracturothelial carcinomageographicfocus
https://clarivate.com/life-sciences-healthcare/report/dlsfon0012-2026-biopharma-bladder-cancer-and-upper-tract-urothelial-carcinoma-landscape-forecast-disease-landscape/
The treatment landscape for bladder cancer and upper tract urothelial carcinoma (UTUC) continues to evolve with the expanding role of immune checkpoint...
bladder cancerupper tracturothelial carcinomalandscapeforecast
https://curie.fr/publications/reappraisal-her2-status-spectrum-advanced-urothelial-carcinoma-need-guidelines-treatment-eligibility
Retrouvez Reappraisal of HER2 status in the spectrum of advanced urothelial carcinoma: a need of guidelines for treatment eligibility. L'Institut Curie est le...
reappraisalstatusspectrumadvancedurothelial
https://clarivate.com/life-sciences-healthcare/report/dlsfon0012-2022-biopharma-bladder-cancer-and-upper-tract-urothelial-carcinoma-disease-landscape-forecast-g7-2022/
Immune checkpoint inhibitors have greatly altered the treatment landscape for urothelial carcinoma. Initially confined to advanced disease, the anti-PD-1...
bladder cancerupper tracturothelial carcinomadiseaselandscape
https://www.pharmaceutical-technology.com/data-insights/arts-021-avenzo-therapeutics-metastatic-transitional-urothelial-tract-cancer-likelihood-of-approval/
ARTS-021 is under clinical development by Avenzo Therapeutics and currently in Phase II for Metastatic Transitional (Urothelial) Tract Cancer.
artstherapeuticsmetastatictransitionalurothelial
https://www.pharmaceutical-technology.com/data-insights/alx-oncology-files-patent-for-treatment-of-urothelial-cancer-using-fusion-polypeptide-and-enfortumab-vedotin/
Discover a groundbreaking patent by ALX Oncology for treating urothelial cancer with fusion polypeptides and enfortumab vedotin. Learn about the innovative...
meta titleurothelial canceralxoncologyholdings
https://uroweb.org/guidelines/upper-urinary-tract-urothelial-cell-carcinoma/chapter/disease-management
The European Association of Urology (EAU) NMIBC Guidelines Panel has compiled these clinical guidelines to provide urologists with evidence-based information...
upper urinary tracturothelial cell carcinomaeauguidelinesdisease
https://www.pharmaceutical-technology.com/data-insights/vaxinia-imugene-transitional-cell-cancer-urothelial-cell-cancer-likelihood-of-approval/?utm_source=lgp5-loa&utm_medium=24-282554&utm_campaign=recommended-articles-pi
VAXINIA is under clinical development by Imugene and currently in Phase I for Transitional Cell Cancer (Urothelial Cell Cancer).
transitional cell cancerimugeneurothelial
https://www.mdanderson.org/cancerwise/urothelial-carcinoma--8-insights-about-this-common-bladder-cancer.h00-159697545.html
Urothelial carcinoma is the most common type of bladder cancer. Here, genitourinary medical oncologist Omar Alhalabi, M.D., shares more about this disease,...
urothelial carcinomabladder cancerinsightscommonmd
https://www.mdpi.com/2077-0383/11/8/2208
Platinum-based chemotherapy is the standard of care with concern to first-line systemic therapy for metastatic disease in urothelial cancer (UC). Resistance to...
therapeutic targeturothelial cancerpotential
https://www.ajmc.com/view/keynote-361-study-for-advanced-urothelial-carcinoma
A review of the KEYNOTE-361 study and recent findings of the post-hoc analysis looking at long-term results of pembrolizumab vs chemotherapy as first-line...
urothelial carcinomakeynotestudyadvancedajmc
https://www.medstarhealth.org/services/cancer-of-the-renal-pelvis-and-ureter
Signs and symptoms of cancer of the renal pelvis and ureter may include flank or back pain or blood in the urine. Learn more about our diagnostics and...
renal pelviscancerureterurothelialmedstar